Russell Investments Group
GWPH

Russell Investments Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Russell Investments Group’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-4,303
Closed -$520K – 3084
2017
Q1 		$520K Buy
+4,303
New +$528K ﹤0.01% 2411

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Russell Investments Group's GWPH Position: Q2 2017 in Review

Russell Investments Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2017, closing a stake of 4,303 shares — an estimated $520K sold.

Russell Investments Group first reported a position in GWPH in Q1 2017 and held it in 1 quarter. The position peaked at $520K in Q1 2017. 170 funds tracked by Wall St. Rank hold GWPH as of Q2 2017.

  • Russell Investments Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2017 after selling out during the quarter.
  • Russell Investments Group sold 4,303 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2017, an estimated $520K.
  • Russell Investments Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2017 and held it in 1 quarter.
  • Russell Investments Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $520K in Q1 2017.
  • 170 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2017.

Based on Russell Investments Group's 13F filing for Q2 2017, filed 25 Jul 2017.